ISSUES AND CONTROVERSIES IN PRIMARY PTCA
Outcomes Following Coronary Stenting: A National Study of Long Term, Real-World Outcomes of Bare-Metal and Drug-Eluting Stents Pamela S. Douglas, J. Matthew.
Late Results from the PAINT trial PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for.
Smh travelhealth pwrpont
STAR HEALTH INSURANCE COIMBATORE
Anesthesia for Cardiac Surgery Jonathan Parmet M.D. Society Hill Anesthesia Consultants.
“Oral Anticoagulant and Antiplatelet combinations: Benefits and Risks ” John Fanikos, BS Pharm, MBA Brigham and Women’s Hospital February 2015.
1 The Safety and Efficacy Of Cangrelor, a Short Acting, IV, Reversible, Platelet P2Y 12 Inhibitor In Patients Awaiting Cardiac Surgery: Results Of the.
Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine (ISO 9001:2008 CERTIFIED) Sri Ramachandra University.
Percutaneous Insertion: Use and Contraindications
Call for CASES Silesian Medical School, Katowice, Poland Percutenous Controlled Reperfusion For STEMI P iotr P. Buszman.
CV Risk Reduction, Diabetes Prevention, and TZDs.